- Home
- SONM vs PAVM Comparison
SONM vs PAVM Comparison
Compare SONM & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.89
HOLD
Current Price
$10.47
Company Overview
Basic Information| Metric | SONM | PAVM |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | 107 |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 8.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SONM | PAVM |
|---|---|---|
| Price | $3.89 | $10.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 19.6K | ★ 31.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $58,298,000.00 | N/A |
| Revenue This Year | $127.68 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.52 | $0.21 |
| 52 Week High | $12.30 | $28.44 |
Technical Indicators
Market Signals| Indicator | SONM | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 55.20 |
| Support Level | $0.66 | $0.38 |
| Resistance Level | $7.08 | $10.98 |
| Average True Range (ATR) | 0.42 | 0.68 |
| MACD | -0.14 | -0.11 |
| Stochastic Oscillator | 27.46 | 66.20 |
Price Performance
Historical Comparison SONM
PAVM
About SONM Sonim Technologies Inc.
DNA X Inc operates a digital asset management platform.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.